Filing Details

Accession Number:
0001354488-17-000471
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-05-03 16:06:50
Reporting Period:
2017-05-01
Filing Date:
2017-05-03
Accepted Time:
2017-05-03 16:06:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1410098 Cormedix Inc. CRMD () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189703 M Cora Tellez C/O Cormedix Inc.
1430 Highway 206, Suite 200
Bedminster NJ 07921
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-05-01 4,800 $0.66 124,821 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy Common Stock) $2.24 2027-02-21 40,000 40,000 Direct
Common Stock Restricted Stock Units $0.00 20,714 20,714 Direct
Common Stock Phantom Stock $0.00 3,472 3,472 Direct
Common Stock Phantom Stock $0.00 4,143 4,143 Direct
Common Stock Stock Option (Right to Buy Common Stock) $2.05 2024-04-03 30,000 30,000 Direct
Common Stock Stock Option (Right to Buy Common Stock) $5.62 2025-03-01 50,000 50,000 Direct
Common Stock Phantom Stock $0.00 4,205 4,205 Direct
Common Stock Phantom Stock $0.00 2,873 2,873 Direct
Common Stock Phantom Stock $0.00 1,371 1,371 Direct
Common Stock Phantom Stock $0.00 2,868 2,868 Direct
Common Stock Phantom Stock $0.00 3,645 3,645 Direct
Common Stock Stock Option (Right to Buy Common Stock) $1.91 2026-02-21 100,000 100,000 Direct
Common Stock Phantom Stock $0.00 4,104 4,104 Direct
Common Stock Phantom Stock $0.00 2,767 2,767 Direct
Common Stock Phantom Stock $0.00 4,335 4,335 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2027-02-21 40,000 40,000 Direct
20,714 20,714 Direct
3,472 3,472 Direct
4,143 4,143 Direct
2024-04-03 30,000 30,000 Direct
2025-03-01 50,000 50,000 Direct
4,205 4,205 Direct
2,873 2,873 Direct
1,371 1,371 Direct
2,868 2,868 Direct
3,645 3,645 Direct
2026-02-21 100,000 100,000 Direct
4,104 4,104 Direct
2,767 2,767 Direct
4,335 4,335 Direct
Footnotes
  1. The purchase was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on August 19, 2016.
  2. These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
  3. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board.
  4. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
  5. The options vest 1/3 on the date of grant, 1/3 on the first anniversary of the date of grant, and 1/3 on the second anniversary of the date of grant.